Mode
Text Size
Log in / Sign up

Vitamin D deficiency is associated with 33% higher odds of progression in chronic kidney diseaseVitamin D Deficiency Linked to Faster Chronic Kidney Disease Progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that vitamin D deficiency is associated with higher odds of CKD progression, but evidence is of low certainty.

This meta-analysis evaluates the relationship between serum vitamin D status (25-hydroxyvitamin D) and the progression of chronic kidney disease (CKD). The analysis found that vitamin D deficiency is associated with 33% higher odds of CKD progression (OR = 1.33; 95% CI: 1.06-1.67; P = 0.019). A dose-response analysis showed that for every 10 ng/mL lower 25(OH)D concentration, the odds of progression increased (OR = 1.18; 95% CI: 1.09-1.25).

Subgroup analyses revealed stronger associations in specific contexts. Studies with a follow-up of 5 years or more showed an OR of 2.07 (95% CI: 1.29-3.14; P = 0.001), and high-quality studies showed an OR of 1.35 (95% CI: 1.06-1.69; P = 0.03). The authors noted significant limitations, including considerable between-study heterogeneity (I-squared = 98.2%) and the fact that dose-response interpretations were limited by reconstructed category-level exposure values.

Due to the observational nature of the included studies, these findings do not establish a causal link. The GRADE assessment indicates very low certainty for the overall association and low certainty for the dose-response analysis. Consequently, these findings do not support the conclusion that routine screening or vitamin D supplementation can prevent renal function decline.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the role of nutritional markers in chronic kidney disease. While previous coverage noted that elevated glucose, chloride, and anion gap levels are associated with increased risk of acute kidney injury, this study focuses on the specific association between vitamin D status and CKD progression. It provides a quantified association between vitamin D levels and progression, though it does not establish causality.

A review of existing research looked at the link between vitamin D levels and the progression of chronic kidney disease. The analysis focused on patients with established kidney issues to see if their vitamin D status related to how quickly their condition progressed.

Researchers found that patients with vitamin D deficiency had 33% higher odds of seeing their kidney disease progress. This link appeared even stronger in high-quality studies and in studies that followed patients for five years or more. The data also suggested that for every 10 ng/mL drop in vitamin D, the risk of progression increased.

It is important to note that these findings come from observational studies, which show a link but do not prove that vitamin D causes kidney health. There was also a lot of variation between the different studies included in this review. Because the evidence is of low certainty, it does not mean that routine screening or vitamin D supplements are proven to stop kidney decline.

What this means for you:
Low vitamin D is linked to faster kidney disease progression, but more research is needed to prove a cause.

Common questions

Is low vitamin D a proven cause of kidney disease progression?

The study shows a link between low vitamin D and a 33% higher risk of kidney disease progression. However, because the data comes from observational studies, it does not prove that low vitamin D causes the progression. You should speak with your doctor about what these results mean for your specific health needs.

Does the amount of vitamin D matter for kidney health?

The data suggests a dose-response relationship. For every 10 ng/mL lower concentration of 25(OH)D, there were higher odds of kidney disease progression. However, the certainty of this specific finding is low because of how the data was grouped in the analysis.

Are these findings reliable for long-term patients?

The link between low vitamin D and kidney progression appeared even stronger in studies that followed patients for 5 years or more. While the association is clear in these larger studies, the overall certainty of the evidence is considered very low due to differences between the studies.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up60.0 mo
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: This systematic review and dose-response meta-analysis aimed to evaluate the association between serum vitamin D status and chronic kidney disease (CKD) progression. METHODS: We searched PubMed, Scopus, Web of Science, and Embase for relevant observational and cohort studies published between 1990 and 2024. Eligible studies reported baseline vitamin D levels and CKD progression outcomes. We performed a random-effects meta-analysis to calculate the pooled odds ratio (OR) for CKD progression. A dose-response meta-analysis examined the relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and risk, while subgroup analyses explored follow-up duration, study quality, and comorbid conditions. We assessed evidence certainty using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: Eleven studies met the inclusion criteria. The pooled analysis suggested that vitamin D deficiency was associated with 33% higher odds of CKD progression (OR = 1.33, 95% confidence interval [CI]: 1.06-1.67; P = .019); however, between-study heterogeneity was considerable (I-squared heterogeneity statistic [I2] = 98.2%). The pooled estimate should therefore be interpreted cautiously as an average association across heterogeneous studies. A dose-response analysis of 10 studies suggested higher odds of CKD progression per 10 ng/mL lower 25(OH)D concentration (OR = 1.18, 95% CI: 1.09-1.25), although its interpretation was limited by reconstructed category-level exposure values. Subgroup analyses showed stronger associations in studies with long-term follow-up (≥5 years; OR = 2.07, 95% CI: 1.29-3.14; P = .001) and high-quality studies (OR = 1.35, 95% CI: 1.06-1.69; P = .03). The Grading of Recommendations Assessment, Development and Evaluation assessment rated the certainty of evidence as very low for the overall association and low for the dose-response analysis, primarily because of the observational study designs and substantial between-study heterogeneity. CONCLUSION: Lower serum 25(OH)D levels were associated with higher odds of CKD progression. However, the observational nature of the evidence does not establish that routine screening or vitamin D supplementation can prevent renal function decline. Prospective studies and randomized trials are needed to clarify the clinical utility of vitamin D assessment and supplementation for renal outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.